Randomized trial of stents versus bypass surgery for left main coronary artery disease: 5-year outcomes of the PRECOMBAT study

Journal of the American College of Cardiology

Volumn 65, Issue 20, 2015, Pages 2198-2206

  Ahn, Jung Min ^a   Roh, Jae Hyung ^a   Kim, Young Hak ^a   Park, Duk Woo ^a   Yun, Sung Cheol ^a   Lee, Pil Hyung ^a   Chang, Mineok ^a   Park, Hyun Woo ^a   Lee, Seung Whan ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a   Choo, Suk Jung ^a   Chung, Cheolhyun ^a   Lee, Jaewon ^a   Lim, Do Sun ^b   Rha, Seung Woon ^c   Lee, Sang Gon ^d   Gwon, Hyeon Cheol ^e   Kim, Hyo Soo ^f   Chae, In Ho ^f   Jang, Yangsoo ^g   Jeong, Myung Ho ^h   Tahk, Seung Jea ⁱ   Seung, Ki Bae ^j   Park, Seung Jung ^a   more..

^a University of Ulsan College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea University   (South Korea)

^d Ulsan University College of Medicine   (South Korea)

^e Samsung Medical Center   (South Korea)

^f Seoul National University Hospital   (South Korea)

^g Yonsei University   (South Korea)

^h Chonnam National University Medical School   (South Korea)

ⁱ Ajou University Medical Center   (South Korea)

^j The Catholic University of Korea   (South Korea)

more..

Author keywords

coronary artery bypass grafting; long term outcome; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; TICLOPIDINE; RAPAMYCIN;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; FEMALE; FOLLOW UP; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; INTENTION TO TREAT ANALYSIS; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OPEN STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SILENT MYOCARDIAL ISCHEMIA; SIROLIMUS ELUTING CORONARY STENT; STABLE ANGINA PECTORIS; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG ELUTING STENT; MIDDLE AGED; MULTICENTER STUDY; TIME;

AGED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84929611337     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.03.033     Document Type: Article

References (25)

1. S. Yusuf, D. Zucker, and P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
2. A. Chieffo, G. Stankovic, and E. Bonizzoni Early and mid-term results of drug-eluting stent implantation in unprotected left main Circulation 111 2005 791 795
3. S.J. Park, Y.H. Kim, and B.K. Lee Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation J Am Coll Cardiol 45 2005 351 356
4. E. Meliga, H.M. Garcia-Garcia, and M. Valgimigli Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry J Am Coll Cardiol 51 2008 2212 2219
5. K.B. Seung, D.W. Park, and Y.H. Kim Stents versus coronary-artery bypass grafting for left main coronary artery disease N Engl J Med 358 2008 1781 1792
6. M.C. Morice, P.W. Serruys, and A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
7. S.J. Park, Y.H. Kim, and D.W. Park Randomized trial of stents versus bypass surgery for left main coronary artery disease N Engl J Med 364 2011 1718 1727
8. Authors/Task Force Members L. Ryden, P.J. Grant, and S.D. Anker ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) Eur Heart J 34 2013 3035 3087
9. A. Chieffo, E. Meliga, and A. Latib Drug-eluting stent for left main coronary artery disease. The DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment J Am Coll Cardiol Intv 5 2012 718 727
10. K. Chang, Y.S. Koh, and S.H. Jeong Long-term outcomes of percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main coronary bifurcation disease in the drug-eluting stent era Heart 98 2012 799 805
11. A. Chieffo, V. Magni, and A. Latib 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: the Milan experience J Am Coll Cardiol Intv 3 2010 595 601
12. D.W. Park, Y.H. Kim, and S.C. Yun Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry J Am Coll Cardiol 56 2010 1366 1375
13. E. Boudriot, H. Thiele, and T. Walther Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis J Am Coll Cardiol 57 2011 538 545
14. M.P. Sa, P.E. Ferraz, and R.R. Escobar Five-year outcomes following PCI with DES versus CABG for unprotected LM coronary lesions: meta-analysis and meta-regression of 2914 patients Rev Bras Circ Cardiovasc 28 2013 83 92
15. M.C. Morice, P.W. Serruys, and A.P. Kappetein Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial Circulation 129 2014 2388 2394
16. A. Schomig, A. Dibra, and S. Windecker A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease J Am Coll Cardiol 50 2007 1373 1380
17. D.W. Park, Y.H. Kim, and S.C. Yun Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial J Am Coll Cardiol 56 2010 1187 1195
18. S.J. Park, Y.H. Kim, and D.W. Park Impact of intravascular ultrasound guidance on long-term mortality in stenting for unprotected left main coronary artery stenosis Circ Cardiovasc Interv 2 2009 167 177
19. H.L. Dauerman Reasonable incomplete revascularization Circulation 123 2011 2337 2340
20. Y.H. Kim, D.W. Park, J.M. Ahn for the PRECOMBAT-2 Investigators Everolimus-eluting stent implantation for unprotected left main coronary artery stenosis. The PRECOMBAT-2 (Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) study J Am Coll Cardiol Intv 5 2012 708 717
21. M.E. Farkouh, M. Domanski, L.A. Sleeper for the FREEDOM Trial Investigators Strategies for multivessel revascularization in patients with diabetes N Engl J Med 367 2012 2375 2384
22. S.J. Head, P.M. Davierwala, and P.W. Serruys Coronary artery bypass grafting vs. Percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial Eur Heart J 35 2014 2821 2830
23. Y.H. Kim, D.W. Park, and W.J. Kim Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization J Am Coll Cardiol Intv 3 2010 612 623
24. Y.J. Zhang, J. Iqbal, and C.M. Campos Prognostic value of site SYNTAX score and rationale for combining anatomic and clinical factors in decision making: insights from the SYNTAX trial J Am Coll Cardiol 64 2014 423 432
25. V. Farooq, D. van Klaveren, and E.W. Steyerberg Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II Lancet 381 2013 639 650